COVID-19 and immune-mediated inflammatory diseases: Why don't our patients get worse?
作者信息
Martínez-Taboada Víctor M, López-Hoyos Marcos, Crespo Javier, Hernández José L
机构信息
Division of Rheumatology, Hospital Marqués de Valdecilla-IDIVAL, Santander, Spain; University of Cantabria, Santander, Spain.
Division of Immunology, Hospital Marqués de Valdecilla-IDIVAL, Santander, Spain.
出版信息
Autoimmun Rev. 2020 Dec;19(12):102683. doi: 10.1016/j.autrev.2020.102683. Epub 2020 Oct 27.
Abstract
摘要
相似文献
1
COVID-19 and immune-mediated inflammatory diseases: Why don't our patients get worse?
Autoimmun Rev. 2020 Dec;19(12):102683. doi: 10.1016/j.autrev.2020.102683. Epub 2020 Oct 27.
2
The immune roadmap for understanding multi-system inflammatory syndrome in children: opportunities and challenges.
Nat Med. 2020 Dec;26(12):1819-1824. doi: 10.1038/s41591-020-1140-9.
3
When patients don't get the care they should.
J Fam Pract. 2020 Nov;69(9):427.
4
Myasthenia Gravis Associated With SARS-CoV-2 Infection.
Ann Intern Med. 2020 Dec 15;173(12):1027-1028. doi: 10.7326/L20-0845. Epub 2020 Aug 10.
5
A new inflammatory-microthrombotic syndrome as an explanation for thrombotic complications in patients with COVID-19.
Rev Esp Cardiol (Engl Ed). 2021 Jan;74(1):115-116. doi: 10.1016/j.rec.2020.08.021. Epub 2020 Oct 2.
6
COVID-19 in patients with cutaneous immune-mediated diseases in The Netherlands: real-world observational data.
J Eur Acad Dermatol Venereol. 2021 Mar;35(3):e173-e176. doi: 10.1111/jdv.17025. Epub 2020 Nov 22.
7
Coronavirus Disease 2019 (SARS-CoV-2) and polycystic ovarian disease: Is there a higher risk for these women?
J Steroid Biochem Mol Biol. 2021 Jan;205:105770. doi: 10.1016/j.jsbmb.2020.105770. Epub 2020 Oct 13.
8
Association between myocardial injury and prognosis of COVID-19 hospitalized patients, with or without heart disease. CARDIOVID registry.
Rev Esp Cardiol (Engl Ed). 2021 Jan;74(1):105-108. doi: 10.1016/j.rec.2020.08.005. Epub 2020 Aug 15.
9
Why does COVID-19 pathology have several clinical forms?
Bioessays. 2020 Dec;42(12):e2000198. doi: 10.1002/bies.202000198. Epub 2020 Nov 11.
10
The Remote Misses of COVID-19.
Ann Intern Med. 2020 Dec 15;173(12):1010-1011. doi: 10.7326/M20-4984. Epub 2020 Aug 19.
引用本文的文献
1
Platelet-leukocyte crosstalk in COVID-19: How might the reciprocal links between thrombotic events and inflammatory state affect treatment strategies and disease prognosis?
Thromb Res. 2022 May;213:179-194. doi: 10.1016/j.thromres.2022.03.022. Epub 2022 Mar 31.
2
Rise and exacerbation of oral lichen planus in the background of SARS-CoV-2 infection.
Med Hypotheses. 2021 Nov;156:110681. doi: 10.1016/j.mehy.2021.110681. Epub 2021 Sep 20.
本文引用的文献
1
Clinical course, severity and mortality in a cohort of patients with COVID-19 with rheumatic diseases.
Ann Rheum Dis. 2020 Dec;79(12):1659-1661. doi: 10.1136/annrheumdis-2020-218054. Epub 2020 Jun 30.
2
Low frequency of COVID-19 in inflammatory bowel diseases.
Dig Liver Dis. 2020 Nov;52(11):1234-1235. doi: 10.1016/j.dld.2020.06.007. Epub 2020 Jun 13.
3
COVID-19 and psoriasis: biologic treatment and challenges.
J Dermatolog Treat. 2022 Mar;33(2):699-703. doi: 10.1080/09546634.2020.1789051. Epub 2020 Jul 6.
4
Zero COVID-19 infection in inflammatory bowel disease patients: Findings from population-based inflammatory bowel disease registries in Hong Kong and Taiwan.
J Gastroenterol Hepatol. 2021 Jan;36(1):171-173. doi: 10.1111/jgh.15164. Epub 2020 Jul 6.
5
Incidence of severe COVID-19 in a Spanish cohort of 1037 patients with rheumatic diseases treated with biologics and JAK-inhibitors.
Ann Rheum Dis. 2022 Jul;81(7):e131. doi: 10.1136/annrheumdis-2020-218152. Epub 2020 Jun 25.
6
Experience of telemedicine use in a big cohort of patients with rheumatoid arthritis during COVID-19 pandemic.
Ann Rheum Dis. 2021 May;80(5):e65. doi: 10.1136/annrheumdis-2020-218165. Epub 2020 Jun 25.
7
From the American Epicenter: Coronavirus Disease 2019 in Patients with Inflammatory Bowel Disease in the New York City Metropolitan Area.
Inflamm Bowel Dis. 2021 Apr 15;27(5):662-666. doi: 10.1093/ibd/izaa162.
8
Systemic or biologic treatment in psoriasis patients does not increase the risk of a severe form of COVID-19.
J Eur Acad Dermatol Venereol. 2020 Nov;34(11):e676-e679. doi: 10.1111/jdv.16761. Epub 2020 Jul 9.
9
Covid-19 and autoimmunity.
Autoimmun Rev. 2020 Aug;19(8):102597. doi: 10.1016/j.autrev.2020.102597. Epub 2020 Jun 11.
10
Prevalence of hospital PCR-confirmed COVID-19 cases in patients with chronic inflammatory and autoimmune rheumatic diseases.
Ann Rheum Dis. 2020 Sep;79(9):1170-1173. doi: 10.1136/annrheumdis-2020-217763. Epub 2020 Jun 12.
Zotero 插件